Research Papers:

Association of glutathione S-transferase T1 and M1 polymorphisms with prostate cancer susceptibility in populations of Asian descent: a meta-analysis

Da-Long Cao _, Ding-Wei Ye, Bo Dai, Hai-Liang Zhang, Yi-Jun Shen, Yao Zhu, Yi-Ping Zhu, Guo-Hai Shi, Chun-Guang Ma, Wen-Jun Xiao, Xiao-Jian Qin and Guo-Wen Lin

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:35843-35850. https://doi.org/10.18632/oncotarget.5346

Metrics: PDF 766 views  |   HTML 989 views  |   ?  


Da-Long Cao1,2, Ding-Wei Ye1,2, Bo Dai1,2, Hai-Liang Zhang1,2, Yi-Jun Shen1,2, Yao Zhu1,2, Yi-Ping Zhu1,2, Guo-Hai Shi1,2, Chun-Guang Ma1,2, Wen-Jun Xiao1,2, Xiao-Jian Qin1,2, Guo-Wen Lin1,2

1Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China

2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China

Correspondence to:

Ding-Wei Ye, e-mail: dwyeli@163.com

Keywords: prostate cancer, susceptibility, polymorphism, glutathione S-transferases T1, glutathione S-transferases M1

Received: June 21, 2015     Accepted: September 14, 2015     Published: September 24, 2015


Background: Genetic polymorphism was hypothesized to be reason of variation in prostate cancer incidence among different racial group. Based on that published data on the association of prostate cancer susceptibility with polymorphisms in genes encoding Glutathione S-transferases (GSTs) were inconclusive, the aim of this study was to more precisely address the role of GSTs polymorphisms (especially, GSTT1 and GSTM1 deletions) on prostate cancer risk in Asian descent.

Methods: A meta-analysis including 8 articles with 711 cases and 1122 controls for GSTT1 and 1098 cases and 1588 controls for GSTM1 was performed.

Results: Significantly increased prostate cancer risk was found among subjects carrying GSTM1 null genotype (odds ratio (OR) = 1.403; 95% confidence interval (CI) = 1.088 – 1.808) but not among subjects carrying GSTT1 deletion genotype (OR = 0.959; 95%CI = 0.709 – 1.297). When stratified by country, the null genotype of GSTT1 neither increased nor decreased prostate cancer risk significantly in China (OR = 1.355; 95%CI = 0.895 – 2.049), Japan (OR = 0.812; 95%CI = 0.545 – 1.211), and Korea (OR = 1.056; 95%CI = 0.727 – 1.534). While significant association of elevated prostate cancer risk with GSTM1 deletion were found in China (OR = 1.665; 95%CI = 1.324 – .094) and Korea (OR = 1.914; 95%CI = 1.311 – 2.793) but not in Japan (OR = 0.980; 95%CI = 0.726 – 1.321).

Conclusion: In summary, this meta-analysis suggested that the null genotype of GSTM1 rather than GSTT1 may be involved in the etiology of prostate cancer in Asian population.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 5346